Webinars
ProFound Insights, ProFound Impact: Why Kettering Health Traded out Previous AI Software for ProFound AI® Enterprise-Wide
Wednesday, April 27, 2022 Experience a compelling conversation featuring leading experts in breast imaging and hospital administration from Kettering Health, a leading enterprise breast care provider with 14 breast centers across southwest Ohio, and discover how iCAD’s world-class AI breast health solutions offer a trifecta of unrivaled, clinically proven benefits…
Solutions d’intelligence artificielle pour la détection du cancer du sein et l’évaluation du risque
Mardi 19 avril 2022 Près de 5 millions de mammographies sont effectuées en France chaque année. Les solutions d’IA pour la détection du cancer du sein sont devenues une aide précieuse au quotidien pour les radiologues. Panorama sur la mise en place l’IA pour la détection du cancer du sein…
Symposium, JFR21: L’intelligence artificielle pour la détection précoce du cancer du sein
Dimanche 10 octobre Le Dr Arfi Rouche de l’Institut Gustave Roussy et le Dr Toubiana du C.S.E à Paris, reviennent sur les différentes études cliniques montrant les performances des solutions ProFound AI® pour une meilleure détection du cancer du sein. Ils expliquent comment ces solutions qui font aujourd’hui parties intégrantes…
Pandemic Recovery: How New Technology Can Support Clinicians and Patients in the Aftermath of COVID-19
Tuesday, September 14, 2021 As we shift from the peak of the pandemic to recovery mode, clinicians are in need of new solutions to navigate today’s challenges. During this virtual event, leading experts from the breast care community shared insights about new innovations in imaging and risk-assessment that may help…
What is Real AI: Adopting Artificial Intelligence
Tuesday, September 15, 2020 This free virtual roundtable will feature leading experts in artificial intelligence (AI) and cancer detection, who will share best practices on how to leverage AI in a clinical setting – in the era of COVID-19 and beyond. Join us to learn how AI can improve efficiency…
Webinaire, L’Intelligence Artificielle pour une meilleure détection du cancer du sein
Tuesday, July 21, 2020 Intraoperative radiation therapy (IORT) offers a unique trifecta of benefits for clinicians, patients, and payers. In partnership with the Society for Radiation Oncology Administrators (SROA), leading breast cancer specialists will share clinical experiences and expert opinions regarding this targeted, single-fraction radiation treatment option, which optimizes workflow…
GE Healthcare: Making AI Meaningful – How AI is Being Used to Transform Radiology Practices
Thursday, May 28, 2020 The use of Artificial Intelligence (AI) in radiological applications is no longer an idea – it is becoming a necessity to help deliver the highest possible patient care. Just as PACS and RIS systems were the crucial infrastructure implementation of the last 20 years in the…
How Radiologists can Easily and Effortlessly Integrate Artificial Intelligence in Breast Screening During and After the COVID-19 Crisis
Monday, May 18, 2020 Michael Gruber, MD, will explain how he uses ProFound AI in his breast screening program, how AI was easy to implement and immediately assisted him in addressing the challenges of tomosynthesis.
Live Roundtable Replay and Q&A with Dr. Randy Hicks: Breast Cancer Screening and Treatment in the Era of COVID-19
Thursday, May 7, 2020 In partnership with the Targeted Medical Education (TME) Breast Care Network, our Virtual Roundtable Event featured leading breast cancer specialists nationwide who discussed their perspectives and experience regarding how COVID-19 is changing the future of breast cancer care.
Assisting Radiologists: How can AI Improve the Efficiency of Breast Healthcare After COVID-19?
Monday, May 4, 2020 How can AI improve the efficiency of breast healthcare after COVID-19 and help radiologists with their increased workload? After the COVID-19 crisis, radiologists will have to deal with an influx of patients due to rescheduled examinations. * Webinar intended for an EU audience.